Top McKesson Corporation Competitors and Alternatives | Bullfincher

+

Ticker

MCK

CAH

Headquarter

Irving ,TX

US

Dublin ,OH

US

CEO

Mr. Brian S. Tyler Ph.D.

Mr. Jason M. Hollar

Industry

Medical - Distribution

Medical - Distribution

Stock Price

Stock Price

Market Cap

$73.30B

$28.87B

Employees

Years

2022
2023
2024

2022
2023
2024

Employees

75.00K
51.00K
51.00K

46.50K
48.00K
48.90K

Y/Y

1.32%

32%

0%

1.69%

3.23%

1.88%

Income Statement

Revenue

Years

2022
2023
2024

2022
2023
2024

Revenue

$263.97B
$276.71B
$308.95B

$181.36B
$205.01B
$226.83B

Y/Y

10.8%

4.83%

11.65%

11.63%

13.04%

10.64%

Revenue by Products / Services

Revenue by Geography

Research and Development

Years

2022
2023
2024

2022
2023
2024

Research and Development

$70.00M
$89.00M
$179.00M

-
-
-

Y/Y

5.41%

27.14%

101.12%

0%

0%

0%

Operating Income

Years

2022
2023
2024

2022
2023
2024

Operating Income

$2.85B
$4.38B
$3.91B

$1.65B
$727.00M
$1.24B

Y/Y

19.02%

53.61%

10.77%

10.48%

55.89%

70.98%

Tax Rate (%)

Years

2022
2023
2024

2022
2023
2024

Tax Rate (%)

33.00%
20.00%
17.00%

-21.00%
59.00%
29.00%

Y/Y

138.88%

40.74%

15.09%

76.3%

377.97%

50.82%

Net Income

Years

2022
2023
2024

2022
2023
2024

Net Income

$1.11B
$3.56B
$3.00B

-$932.00M
$261.00M
$852.00M

Y/Y

125.67%

219.57%

15.67%

252.54%

128%

226.44%

Assets & Liabilities | Cash Flow

Total Assets

Years

2022
2023
2024

2022
2023
2024

Total Assets

$63.30B
$62.32B
$67.44B

$43.88B
$43.42B
$45.12B

Y/Y

2.64%

1.55%

8.22%

1.29%

1.05%

3.92%

Total Liabilities

Years

2022
2023
2024

2022
2023
2024

Total Liabilities

$65.09B
$63.81B
$69.04B

$44.58B
$46.27B
$48.33B

Y/Y

2.39%

1.97%

8.2%

4.51%

3.78%

4.46%

Capital Expenditures (Capex)

Years

2022
2023
2024

2022
2023
2024

Capital Expenditures (Capex)

-$535.00M
-$558.00M
-$687.00M

-$387.00M
-$481.00M
-$511.00M

Y/Y

16.54%

4.3%

23.12%

3.25%

24.29%

6.24%

Profitability

Operating Income Margin (%)

Years

2022
2023
2024

2022
2023
2024

Operating Income Margin (%)

1.08%
1.58%
1.27%

0.91%
0.35%
0.55%

Y/Y

27.03%

46.3%

19.62%

19.47%

61.54%

57.14%

Net Income Margin (%)

Years

2022
2023
2024

2022
2023
2024

Net Income Margin (%)

0.42%
1.29%
0.97%

-0.51%
0.13%
0.38%

Y/Y

123.08%

207.14%

24.81%

234.21%

125.49%

192.31%

EBITDA

2021	-3596000000.00
2022	3107000000.00
2023	5735000000.00
2024	4667000000.00

2021	1310000000.00
2022	126000000.00
2023	1441000000.00
2024	1978000000.00

Years

2022
2023
2024

2022
2023
2024

EBITDA

$3.11B
$5.74B
$4.67B

$126.00M
$1.44B
$1.98B

Y/Y

186.4%

84.58%

18.62%

90.38%

1043.65%

37.27%

Free Cash Flow (FCF)

2021	3901000000.00
2022	3899000000.00
2023	4601000000.00
2024	3627000000.00

2021	2029000000.00
2022	2735000000.00
2023	2358000000.00
2024	3251000000.00

Years

2022
2023
2024

2022
2023
2024

Free Cash Flow (FCF)

$3.90B
$4.60B
$3.63B

$2.74B
$2.36B
$3.25B

Y/Y

0.05%

18%

21.17%

34.8%

13.78%

37.87%

Ratios

Return on Equity (ROE)

Years

2022
2023
2024

2022
2023
2024

Return on Equity (ROE)

-49.03%
-191.71%
-152.31%

132.01%
-9.15%
-26.52%

Y/Y

100.24%

291.01%

20.55%

287.58%

106.93%

189.84%

Return on Assets (ROA)

Years

2022
2023
2024

2022
2023
2024

Return on Assets (ROA)

1.76%
5.71%
4.45%

-2.12%
0.60%
1.89%

Y/Y

126.39%

224.43%

22.07%

254.74%

128.3%

215%

Debt to Equity

Years

2022
2023
2024

2022
2023
2024

Debt to Equity

-263.69%
-308.02%
-292.29%

-752.83%
-164.89%
-158.48%

Y/Y

99.24%

16.81%

5.11%

316.58%

78.1%

3.89%

Valuation

Enterprise Value

Years

2022
2023
2024

2022
2023
2024

Enterprise value

$50.63B
$52.86B
$74.27B

$15.18B
$25.34B
$23.91B

Y/Y

46.98%

4.39%

40.51%

22.14%

66.92%

5.65%

Enterprise value to Revenue

Years

2022
2023
2024

2022
2023
2024

Enterprise value to Revenue

0.19
0.19
0.24

0.08
0.12
0.11

Y/Y

32.64%

0.42%

25.86%

30.25%

47.67%

14.72%

Enterprise value to EBITDA

Years

2022
2023
2024

2022
2023
2024

Enterprise value to EBITDA

16.30
9.22
15.91

120.49
17.59
12.09

Y/Y

270.11%

43.45%

72.66%

709.46%

85.4%

31.26%